Growth hormones anabolic effects in muscle are mediated in part via IGF-I (Kim, Barton, Muja et al., 2005), although IGF-I-independent pathways have also been proposed (Daughaday, 1989, Isaksson, Lindahl, Nilsson et al., 1988, Le Roith, Bondy, Yakar et al., 2001, Sotiropoulos, Ohanna, Kedzia et al., 2006)
June 29-30, 2009: Joint meeting of the Drug Safety and Risk Management Advisory Committee with the Anesthetic and Life Support Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee: FDA briefing material
[DOI] [PubMed] [Google Scholar] 325.Shimizu Y., Chang E.C., Shafton A.D., Ferens D.M., Sanger G.J., Witherington J., Furness J.B
CJC1295 and Ipamorelin are research peptides and are not FDAapproved for antiaging, fat loss, or performance